• 셀메드
• /
• 제14권4호
• /
• pp.74.1-74.4
• /
• 2024

Objective: Case report on hair loss improvement by ortho-cellular nutrition therapy. Methods: A Korean woman in her 60s suffers from hair loss. Results: Hair loss was significantly improved after OCNT. Conclusion: OCNT may help alleviate hair loss symptoms.

• 융합정보논문지
• /
• 제10권4호
• /
• pp.175-183
• /
• 2020

탈모인들은 자신의 이미지 개선과 자신감 극복을 위해 많은 노력을 하고 있다. 그 중 탈모를 위해 착용하는 가발에 대한 수요와 인식의 변화는 좋아지고 있으나 가발 자체의 탈모, 탈색, 엉킴 현상이 발생하고 부자연스러운 헤어 스타일링과 가발 착용에 드는 소요 시간 등 불편한 부분들이 있어 이를 개선한 새로운 시술방법으로 헤어 증모술이 대두되고 있다. 이에 본 연구의 목적은 자신의 모발에 인모 가닥을 엮어 증모시키는 헤어 증모술을 통해 중년 여성 탈모인들의 삶의 질에 긍정적인 영향을 미치는지 검증하는데 있다. 조사 대상자는 중년 탈모여성으로 증모 전, 후 삶의 질을 측정하여 분석하였다. 분석 결과 헤어 증모술이 중년 탈모 여성의 경제적 만족도, 신체적 만족도, 정신적 만족도, 사회적 만족도에 정(+)의 영향을 미치는 것으로 나타나 헤어 증모술이 중년 탈모 여성의 삶의 질을 향상시키는데 효과가 있음을 알 수 있었다. 또한 증모 후 만족도와 재시술 의향도 높아 뷰티 시장의 블루오션인 헤어 증모술을 통해 고부가 가치 창출을 기대할 수 있을 것이라 사료된다.

• 패션비즈니스
• /
• 제11권2호
• /
• pp.76-91
• /
• 2007

The domestic market for scalp care and hair loss management reached 1 trillion won. The market for hair loss management is expected to expand further. Systematic scalp and hair care services, such as scalp scaling, scalp massage, equipment maintenance, scalp care products sale, and care program based on scalp and trichology are provided. This study examined the status of hair loss management and use of hair care products by people experiencing hair loss and the level of their satisfaction. In addition, this study presents basic data for the effective hair loss management and marketing strategies for scalp and hair loss clinics. The results are as follows. 41.2% of the study subjects were in their 20s, and 66.6% of the study subjects were women. As for the hair loss symptoms, 45.2%, the largest percentage, had thin and wispy hair and more women had thin hair than men. 80.0% of men had oily hair. As for the scalp condition, 39,3% had oily scalp. As more women experience hair loss, 39.6% had female pattern hair loss and 31.0% had male pattern hair loss. As the largest percentage of people experiencing hair loss was in their 20s, 33.4%, the largest percentage, had the onset of hair loss in their early 20s. 34.1%, the largest percentage, reported having used the clinic for less than 1 month. The older the subject, the longer the length of hair clinic use. As for the average number of monthly hair loss clinic visits, 28.2%, the largest percentage, said 3 times. As for the hair loss management product use, 61.9%, said they do not use it and 38.1% said they use it. 5.6%, the largest percentage, used Davines at home and 9.6%, the largest percentage, used Kerastase at the clinic. As for the experience of hair loss product previously, 84.5% said they had no experience and 15.5% said they had eThe following are related to the satisfaction level of hair loss management. xperience. 5.0%, the largest percentage, reported having used Daenggimeori. The following are related to the satisfaction level of hair loss management. 32.8%, the largest percentage, said the effect of hair loss management lasted less than 6 monthas. As for the satisfaction levels on hair loss management program, service, skill of the hair specialist, hygiene, and hair loss management products, most people indicated between average and somewhat satisfactory levels. As for the satisfaction level on the cost of hair loss management, most people indicated average satisfaction level. As for the element essential to hair loss management, 39.0%, the largest percentage, indicated development of effective and specialized programs, 28.2%, indicated low price, 25.1%, indicated systematic and professional education of the hair specialist, 4.6%, indicated marketing and promotion, 2.5%, indicated service quality, and 0.6% indicated others.

• 한국융합학회논문지
• /
• 제8권4호
• /
• pp.279-285
• /
• 2017

본 연구는 여성암환우의 가발착용이 두피질환에 미치는 영향을 알아보고 향 후 암 환우들을 위한 가발 제작 시 필요한 기초자료를 제공하고자 실증 조사를 실시하였다. 그 결과 여성암 환우의 탈모용 가발 착용이 두피 가려움증에 미치는 영향은 가발착용 시 여러 가지 불편요소가 클수록 가려움을 유발하는 것으로 나타났으며 가발착용의 밀착성과 땀 분비, 심리적 위축성은 두피 가려움을 직접적으로 유발하지 않는 것으로 나타났다. 또, 여성암환우의 탈모용 가발 착용이 두피 트러블 유발에 미치는 영향에서도 가발의 탈착 시 불편 여부와 심리적 위축감이 높을 경우 두피 트러블을 유발시키는데 유의적인 영향을 미치는 반면 가발 탈착 시 밀착성과 땀 분비는 직접적인 연관이 없는 것으로 나타나 기각되었다. 이 같은 결과는 여성암 환우의 탈모용 가발 작용이 두피가려움과 트러블을 유발시킴에 있어 단순한 밀착여부와 땀 분비만으로 두피질환을 유발하지 않음을 시사한 것으로 볼 수 있다. 따라서 본 연구의 결과를 토대로 심적으로 고통 받는 여성 암 환우들을 위한 편리하고 우수한 가발 제작이 필요할 것으로 생각된다.

• 대한한방내과학회지
• /
• 제38권2호
• /
• pp.235-239
• /
• 2017

This case study describes the effect of Bojungikki-tang on chemotherapy-induced alopecia. Alopecia is a well-documented cause of distress to patients undergoing cancer treatment, but no approved pharmacological treatment exists for chemotherapy-induced hair loss. A 70-year-old female diagnosed with a cholangiocarcinoma and liver metastasis received chemotherapy, including gemcitabine and cisplatin, every three weeks. As a result of the continuous chemotherapy, she suffered various toxicity-related side effects, including bone marrow suppression, general weakness, nausea, peripheral numbness, and hair loss. Bojungikki-tang was initially administered to improve the patient's general weakness and fatigue. After three months of treatment, the patient's hair loss and general condition improved, and the color of the new hair was dark, despite the chemotherapy. The treatment did not improve other symptoms, such as bone marrow suppression and peripheral numbness. This case suggests that Bojungikki-tang could have a beneficial effect on chemotherapy-induced alopecia.

• 셀메드
• /
• 제13권3호
• /
• pp.10.1-10.3
• /
• 2023

Objective: A case report on alopecia improvement using Ortho-Cellular Nutrition Therapy (OCNT) Methods: A 78-year-old Korean female, in which her quality of life has deteriorated due to severe longterm hair loss on the crown and forelocks. Results: Symptoms of alopecia improved after nutritional therapy Conclusion: Nutritional therapy can help to promote hair growth and increase hair thickness for patients who exhibit symptoms of alopecia.

• Archives of Plastic Surgery
• /
• 제44권4호
• /
• pp.332-336
• /
• 2017

Background Little is known concerning hair diameter variation within the safe donor area for hair transplantation surgery. Thicker or thinner hair may be needed, depending on the recipient area, hairline design, and the purpose of surgery. Methods Twenty-seven patients (7 men and 20 women; mean age, 28 years; range, 20-47 years) were included in this study. The midoccipital point was used as the reference point on the horizontal plane at the upper border of the helical rim. The target area width was 15 cm (7.5 cm to the right and left of the reference point) and the height was 8 cm (2 cm above and 6 cm below the reference point). The study area was divided horizontally into 3 5-cm sections (A, B, C) and vertically into 4 2-cm sections (1-4), creating a total of 12 zones. Ten anagen hairs were randomly obtained from each zone and their diameters were measured. Results Hair diameter in the 4 vertical sections varied significantly, gradually decreasing from sections 1 (superior) to 4 (inferior) in all 3 horizontal sections (A, B, and C). Conclusions Our results suggest that sections 1 and 2 of the occipital safe donor area would be useful for obtaining thicker hair, such as in procedures to treat male- and female-pattern hair loss, whereas hair from zones 3 and 4 could be useful for transplantation surgery requiring thinner hair, such as eyebrows, eyelashes, and female hairline correction. Our results may be clinically valuable for planning hair transplant surgery and choosing the optimal donor region.

• Asian Pacific Journal of Cancer Prevention
• /
• 제16권3호
• /
• pp.1225-1233
• /
• 2015

This study aims to clarify the psychosocial reactions of female patients with gynecological cancer undergoing chemotherapy and in the process of suffering from alopecia and to examine their nursing support. The target group comprised female patients who had received two or more cycles of chemotherapy, were suffering from alopecia, and were aged 30-65. Data were collected from semi-structured interviews, conducted from the time the patients were informed by their doctors that they might experience alopecia due to chemotherapy to the time they actually experienced alopecia and until they were able to accept the change. Inductive qualitative analysis was employed to close in on the subjective experiences of the cancer patients. The results showed the existence of six phases in the psychosocial reactions in the process of alopecia: phase one was the reaction after the doctor's explanation; phase two was the reaction when the hair starts to fall out; phase three was the reaction when the hair starts to intensely fall out; phase four was the reaction when the hair has completely fallen out; phase five was the reaction to behavior for coping with alopecia; and phase six was the reaction to change in interpersonal human relationships. The results also made it clear that there are five types of reaction patterns as follows: 1) treatment priority interpersonal relationship maintenance type; 2) alopecia agitated interpersonal relationship maintenance type; 3) alopecia agitated interpersonal relationship reduction type; 4) alopecia denial interpersonal relationship reduction type; and 5) alopecia denial treatment interruption type. It is important to find out which of the five types the patients belong to early during treatment and provide support so that nursing intervention that suits each individual can be practiced. The purpose of this study is to make clear the process in which patients receiving chemotherapy come to accept alopecia and to examine evidence-based nursing care on patients with strong mental distress from alopecia.

• 한국임상수의학회지
• /
• 제31권4호
• /
• pp.341-343
• /
• 2014

A 6-year-old female, shih-tzu was presented in the February with bilateral, symmetrical hair loss and hyperpigmentation on caudal dorsolumbar region. Skin test and blood examination found no remarkable finding. Histopathological examination of biopsies from the alopecic lesions revealed follicular atrophy, infundibular hyperkeratosis and some follicles were twisted truncated and dilated. The diagnosis of recurrent flank alopecia was based on clinical signs and supportive histopathology. Treatment with oral melatonin was started at 3 mg twice daily for 80 days, and by this time complete hair regrowth was observed. The following year in the September, a small non-inflammatory alopecia developed in the same site. The dog was given oral melatonin at 3 mg twice daily for 4 weeks, hair had completely regrown.

• Medical Lasers
• /
• 제9권2호
• /
• pp.150-158
• /
• 2020

Background and Objectives Low-level laser therapy (LLLT) is used widely to promote hair growth in androgenetic alopecia (AGA). This study examined the clinical efficacy and safety of a home-use LLLT device with a newly designed array of light sources and software optimized for individual types of AGA. Materials and Methods The study was a randomized, double-blind, sham device-controlled trial. Forty-eight subjects (39 men and nine women) were assigned randomly in a 2:1 ratio to use either the test device (LG Pra'L HGN1, LG electronics, Korea) or sham device. The subjects used the LLLT device three times a week for 16 weeks. Phototrichogram was used to measure the hair density and hair thickness at 0, 8, and 16-weeks. Adverse events were closely monitored. Results After 16 weeks of using the device, the test group showed a significant increase in hair density and hair thickness compared to the control. In the test group, the hair density increased 6.96 counts/cm² at eight weeks and 13.67 counts/cm² at 16 weeks from the baseline. The hair thickness increased 7.21 ㎛ at eight weeks and 11.80 ㎛ at 16 weeks compared to the baseline. Conclusion The home-use LLLT device with a novel array of light sources and an individualized program according to the types of hair loss appears to be an effective and safe treatment modality for both male and female AGA patients.